- Home
- CVKD vs WVVI Comparison
CVKD vs WVVI Comparison
Compare CVKD & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- WVVI
- Stock Information
- Founded
- CVKD 2022
- WVVI 1983
- Country
- CVKD United States
- WVVI United States
- Employees
- CVKD N/A
- WVVI N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- WVVI Beverages (Production/Distribution)
- Sector
- CVKD Health Care
- WVVI Consumer Staples
- Exchange
- CVKD Nasdaq
- WVVI Nasdaq
- Market Cap
- CVKD 29.5M
- WVVI 28.2M
- IPO Year
- CVKD 2023
- WVVI N/A
- Fundamental
- Price
- CVKD $12.11
- WVVI $4.94
- Analyst Decision
- CVKD Strong Buy
- WVVI
- Analyst Count
- CVKD 1
- WVVI 0
- Target Price
- CVKD $32.00
- WVVI N/A
- AVG Volume (30 Days)
- CVKD 35.2K
- WVVI 26.0K
- Earning Date
- CVKD 08-06-2025
- WVVI 08-12-2025
- Dividend Yield
- CVKD N/A
- WVVI N/A
- EPS Growth
- CVKD N/A
- WVVI N/A
- EPS
- CVKD N/A
- WVVI N/A
- Revenue
- CVKD N/A
- WVVI $38,520,945.00
- Revenue This Year
- CVKD N/A
- WVVI N/A
- Revenue Next Year
- CVKD N/A
- WVVI N/A
- P/E Ratio
- CVKD N/A
- WVVI N/A
- Revenue Growth
- CVKD N/A
- WVVI N/A
- 52 Week Low
- CVKD $5.70
- WVVI $3.17
- 52 Week High
- CVKD $22.90
- WVVI $7.18
- Technical
- Relative Strength Index (RSI)
- CVKD 49.98
- WVVI 32.67
- Support Level
- CVKD $11.00
- WVVI $5.21
- Resistance Level
- CVKD $13.56
- WVVI $5.75
- Average True Range (ATR)
- CVKD 1.15
- WVVI 0.30
- MACD
- CVKD 0.25
- WVVI -0.02
- Stochastic Oscillator
- CVKD 80.97
- WVVI 31.65
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.